IGC Pharma (IGC) Change in Acquisitions & Divestments (2016 - 2021)
IGC Pharma has reported Change in Acquisitions & Divestments over the past 7 years, most recently at -$3.0 million for Q1 2021.
- Quarterly Change in Acquisitions & Divestments changed N/A to -$3.0 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was -$1.2 million through Mar 2022, changed 0.2% year-over-year, with the annual reading at $47000.0 for FY2021, N/A changed from the prior year.
- Change in Acquisitions & Divestments was -$3.0 million for Q1 2021 at IGC Pharma, down from $1.8 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $1.8 million in Q4 2020 and troughed at -$3.0 million in Q1 2021.
- The 4-year median for Change in Acquisitions & Divestments is $2053.0 (2017), against an average of -$185970.8.
- Year-over-year, Change in Acquisitions & Divestments soared 106.42% in 2017 and then tumbled 106.02% in 2018.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $1764.0 in 2017, then tumbled by 332.77% to -$4106.0 in 2018, then soared by 45156.02% to $1.8 million in 2020, then tumbled by 264.0% to -$3.0 million in 2021.
- Per Business Quant, the three most recent readings for IGC's Change in Acquisitions & Divestments are -$3.0 million (Q1 2021), $1.8 million (Q4 2020), and -$4106.0 (Q1 2018).